- Home
- ESCA vs TARA Comparison
ESCA vs TARA Comparison
Compare ESCA & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESCA | TARA |
|---|---|---|
| Founded | 1922 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.2M | 236.1M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ESCA | TARA |
|---|---|---|
| Price | $20.13 | $3.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $24.40 |
| AVG Volume (30 Days) | 44.0K | ★ 374.8K |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | 6.45 | ★ 38.25 |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $180,541,000.00 | $2,948,000.00 |
| Revenue This Year | $4.15 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.82 | ★ N/A |
| Revenue Growth | ★ 2.71 | N/A |
| 52 Week Low | $11.41 | $2.97 |
| 52 Week High | $23.07 | $7.82 |
Technical Indicators
Market Signals| Indicator | ESCA | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 43.60 |
| Support Level | $17.63 | $3.72 |
| Resistance Level | $21.32 | $4.20 |
| Average True Range (ATR) | 1.12 | 0.17 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 36.53 | 34.42 |
Price Performance
Historical ComparisonAbout ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.